CareCloud Consensus Price Target Increased by 27.27% to $7.14
The average one-year price target for CareCloud (NASDAQGM:CCLD) (DB:MTB0) has been revised to $7.14 / share. This is an increase of 27.27% from the prior estimate of $5.61 dated September 11, 2026. These figures represent aggregate analyst targets compiled by Fintel and do not constitute a recommendation orinvestment adviceby Fintel.
The price target is an average of many targets provided by analysts. The latest targets range from a low of $6.06 to a high of $8.40 / share. The average price target represents an increase of 250.00% from the latest reported closing price of $2.04 / share as of October 1, 2026. This target range has narrowed, with the current target range width at $2.34 compared to the prior target range width of $5.88, representing a target range width change percent of -60.17%. The current mean-median gap is $0.00, with the current median target also at $7.14, which increased from a prior median of $6.12.
Looking at the target history, the mean target was $7.14 as of October 2, 2026, and was previously $5.61 on September 15, 2026, August 28, 2026, and August 5, 2026. The observed twelve-month high mean target is $7.14, recorded on October 2, 2026, while the observed twelve-month low mean target is $4.84, recorded on November 9, 2025. The target change since the 90-day baseline date of June 30, 2026, is +27.27%.
In terms of price performance, CareCloud's stock experienced a price change of -0.97% over one week, relative to a baseline close of $2.06 on September 24, 2026. Over one month, the price change was -9.73% from a baseline close of $2.26 on September 1, 2026. For its latest earnings reported on August 6, 2026, CareCloud reported an actual EPS of 0.06, compared to an estimate of 0.0646, representing an EPS surprise percent of -7.12%. Actual revenue was $31,880,000.00, compared to an estimate of $32,487,683.00, which is a revenue surprise percent of -1.87%. The company's upcoming earnings for the third quarter of 2026 are scheduled for October 29, 2026.
CareCloud, Inc., based in the United States, is a prominent player in the healthcare technology sector. The company specializes in providing cloud-based solutions to enhance healthcare operations, focusing on improving practice management, electronic health records, and patient engagement. A significant project undertaken by CareCloud includes the development of an integrated platform that seamlessly consolidates clinical, financial, and operational data to streamline workflows and increase efficiencies across healthcare practices.
Under the GICS classification, CareCloud is positioned in the Information Technology sector, Software industry, and Application Software sub-industry. Within this sub-industry, 23 companies are covered, with 11 raised, 5 lowered, and 7 unchanged. The sub-industry median revision percent is 0.00%, and the median implied change percent is +14.41%. For the recommendation period of September 1, 2026, the total recommendation count was 8, with 75.0% positive recommendations and 25.0% hold recommendations, which is unchanged from the prior recommendation period of August 1, 2026.
Among its peers in the US market, target revisions and implied changes showed mixed directions, ranging from a downward revision for Health Catalyst to a slight upward revision for Phreesia.
| Company | Target revision | Implied change |
|---|---|---|
| Veradigm | 0.00% | — |
| Phreesia | +0.99% | +38.54% |
| Health Catalyst | -3.19% | +6.00% |
Fintel is one of the most comprehensive investing research platforms available to individual investors, traders, financial advisors, and small hedge funds.
Our data covers the world, and includes fundamentals, analyst reports, ownership data and fund sentiment, options sentiment, insider trading, options flow, unusual options trades, and much more. Additionally, our exclusive stock picks are powered by advanced, backtested quantitative models for improved profits.
This story originally appeared on Fintel.